Goldline Pharmaceutical IPO is a ₹11.61 crore SME issue opening on May 12, 2026 and closing on May 14, 2026. The company has fixed the price band at ₹41 to ₹43 per share, and the stock is expected to list on the BSE SME platform on May 19, 2026.

Goldline Pharmaceuticals IPO overview

Goldline Pharmaceutical is a Nagpur-based pharmaceutical marketing company that sells products across therapeutic segments such as cardiology, orthopaedics, paediatrics, diabetes care, critical care, and wellness. Unlike a typical pharma manufacturer, it follows an asset-light model by partnering with third-party manufacturers and focusing on marketing, distribution, and brand building.

The issue is a fresh issue of 27,00,000 equity shares, which means the money raised will largely go into the company rather than promoter exit. The IPO proceeds are mainly planned for debt repayment, along with other general corporate needs.

Key IPO details

Here are the main figures investors should know:

• IPO opens: May 12, 2026
• IPO closes: May 14, 2026
• Price band: ₹41 to ₹43 per
• Issue size: ₹11.61 crore
• Fresh issue: 27,00,000 Lot size: 3,000 shares
• Minimum investment: ₹1,29,000 at the upper price band
• Listing date: May 19, 2026

Because this is an SME IPO, the minimum application amount is relatively high for retail investors. That means the issue is more suitable for investors who are comfortable with SME volatility and higher capital commitment.

Issue Reservation

Goldline Pharmaceutical IPO comprises a total issue size of 27,00,000 shares. The net offer to the public is 25,62,000 shares, after excluding 1,38,000 shares allotted on a firm basis. Of the Net offer 12,72,000 (49.65%) are allocated to QIB, 3,90,000 (15.22%) allocated to NII 9,00,000 (35.13%) allocated to RII.

IPO Lot Size

Investors can bid for a minimum of 6,000 shares and in multiples of 3,000 shares thereof.

Business model

Goldline Pharmaceutical operates in pharmaceutical marketing rather than in-house manufacturing. The company works with third-party manufacturers and distributes products through an asset-light structure, which can help scale business without heavy capex.

Its portfolio covers multiple healthcare segments and is sold across several Indian states, including Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar. That geographic spread gives it a wider market presence, though concentration and dependency risks still matter.

Financial snapshot

Period Ended	31 Dec 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	27.40	26.28	22.93	19.39
Total Income	21.41	28.06	23.57	19.85
Profit After Tax	2.22	2.83	1.81	0.26
EBITDA	4.16	5.83	4.30	2.19
NET Worth	12.36	10.35	7.86	5.89
Reserves and Surplus	3.65	1.65	3.76	2.08
Total Borrowing	9.47	11.03	11.13	10.83
Amount in ₹ Crore

Why investors may watch this IPO

Goldline Pharmaceutical may appeal to investors who like small-cap and SME growth stories in the healthcare distribution space. The asset-light model can be attractive because it reduces manufacturing overhead and allows faster expansion through partnerships.

At the same time, the issue size is modest, and SME liquidity after listing can be limited. Investors should also watch debt repayment plans, related-party exposure, and reliance on third-party manufacturing.

How To Apply for the IPO ?

• Login or Open demat account with JM Financial Services / JM PRO app: Open the JM PRO app or JM Financial Services website and log in with your credentials. 

• Locate the IPO Section: Navigate to the 'IPO' section on the platform. 
• Select IPO: Find and select the IPO from the list of open IPOs. 
• Enter the Lot Size: Specify the number of lots you want to bid for. 
• Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application. 
• Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN. 

How To Check the Allotment Status of IPO?

Steps to check IPO allotment status on JM Pro app: 

• Log in to the JM Pro app. 
• Go to the IPO Section and then to IPO Orders. 
• Select the individual IPO that you had applied for and check the allotment status. 

JM Financial Services will notify you of your IPO allotment status via push notification and email

FAQs

1. What are Goldline Pharmaceutical IPO dates?
The IPO opens on May 12, 2026 and closes on May 14, 2026.

2. What is the price band of Goldline Pharmaceutical IPO?
The price band is ₹41 to ₹43 per share.

3. What is the issue size?
The issue size is ₹11.61 crore.

4. What is the lot size?
The lot size is 3,000 shares.

5. What is the minimum investment?
The minimum investment is ₹1,29,000 at the upper price band.

6. When is the listing date?
The tentative listing date is May 19, 2026 on BSE SME.

7. What does Goldline Pharmaceutical do?
It is a pharmaceutical marketing company that uses an asset-light model and third-party manufacturing.chanakyanipothi+2

8. What are the company’s FY25 financials?
Revenue was ₹28.06 crore and PAT was ₹2.83 crore.